- Home
- LGHL vs NUWE Comparison
LGHL vs NUWE Comparison
Compare LGHL & NUWE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LGHL
- NUWE
- Stock Information
- Founded
- LGHL 2015
- NUWE 1999
- Country
- LGHL Singapore
- NUWE United States
- Employees
- LGHL N/A
- NUWE N/A
- Industry
- LGHL Investment Bankers/Brokers/Service
- NUWE Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- LGHL Finance
- NUWE Health Care
- Exchange
- LGHL Nasdaq
- NUWE Nasdaq
- Market Cap
- LGHL 3.3M
- NUWE 2.9M
- IPO Year
- LGHL N/A
- NUWE N/A
- Fundamental
- Price
- LGHL $7.40
- NUWE $2.46
- Analyst Decision
- LGHL
- NUWE
- Analyst Count
- LGHL 0
- NUWE 0
- Target Price
- LGHL N/A
- NUWE N/A
- AVG Volume (30 Days)
- LGHL 13.0K
- NUWE 128.0K
- Earning Date
- LGHL 01-01-0001
- NUWE 11-12-2025
- Dividend Yield
- LGHL N/A
- NUWE N/A
- EPS Growth
- LGHL N/A
- NUWE N/A
- EPS
- LGHL N/A
- NUWE N/A
- Revenue
- LGHL N/A
- NUWE $8,167,999.00
- Revenue This Year
- LGHL N/A
- NUWE $6.53
- Revenue Next Year
- LGHL N/A
- NUWE $51.63
- P/E Ratio
- LGHL N/A
- NUWE N/A
- Revenue Growth
- LGHL N/A
- NUWE N/A
- 52 Week Low
- LGHL $3.93
- NUWE $2.02
- 52 Week High
- LGHL $213.20
- NUWE $70.14
- Technical
- Relative Strength Index (RSI)
- LGHL 91.64
- NUWE 43.44
- Support Level
- LGHL $0.30
- NUWE $2.02
- Resistance Level
- LGHL $0.93
- NUWE $2.71
- Average True Range (ATR)
- LGHL 0.24
- NUWE 0.20
- MACD
- LGHL 0.41
- NUWE 0.01
- Stochastic Oscillator
- LGHL 95.79
- NUWE 47.25
About LGHL Lion Group Holding Ltd.
Lion Group Holding Ltd is an investor-focused trading platform that offers various products and services. The company's current business lines include total return swap (TRS) trading business, contracts for difference (CFD) trading services, Hong Kong-based Over-The-Counter (OTC) stock options trading business, and futures and securities brokerage services. It provides these services through its Lion Brokers Pro and a variety of other applications. The company generates a majority of its revenue from its CFD trading services business. Geographically, the firm's key revenue-generating market is Hong Kong.
About NUWE Nuwellis Inc.
Nuwellis Inc is a medical technology company focused on developing, manufacturing, and commercializing a medical device used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Nuwellis has one reportable segment: fluid overload.